Study to Evaluate Menses Induction in Women Administered Proellex

NCT00881608 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Repros stopped study for safety and the FDA put the study on hold for safety.

Conditions

Amenorrhea

Interventions

DRUG: Placebo
DRUG: Proellex

Sponsor

Repros Therapeutics Inc.